Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.
Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites. Immunology. 2010 Jul; 130(3):363-73.
-
Animals
-
Antibodies, Monoclonal
-
Antigens, CD
-
Antigens, Differentiation, T-Lymphocyte
-
CD4-Positive T-Lymphocytes
-
CD8-Positive T-Lymphocytes
-
Cell Line, Tumor
-
Cell Proliferation
-
Cytokines
-
Cytotoxicity, Immunologic
-
Female
-
Interferon-gamma
-
Lectins, C-Type
-
Lymph Nodes
-
Lymphocyte Activation
-
Lymphocyte Depletion
-
Melanoma, Experimental
-
Mice
-
Mice, Inbred BALB C
-
Mice, Inbred C3H
-
Mice, Inbred C57BL
-
Mice, Inbred DBA
-
Mice, Nude
-
Mice, Transgenic
-
Neoplasms
-
Ovalbumin
-
Receptors, Immunologic
-
T-Lymphocytes, Cytotoxic
-
Transfection